免疫性细胞死亡:解锁联合辐射和免疫治疗潜力的关键
bioRxiv : the preprint server for biology
|March 3, 2025
概括
这项研究模拟了免疫细胞死亡 (ICD) 如何改善联合癌症疗法. 用放射治疗 (RT) 和巨细胞向SIRPα-CD47检查点可以最大限度地提高抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
- 数学建模的数学建模
背景情况:
- 免疫细胞死亡 (ICD) 释放瘤抗原并激活抗瘤免疫力,但其在组合疗法中的作用尚未研究.
- 放射治疗 (RT) 和基于巨细胞的免疫治疗是关键的癌症治疗方法,通过ICD有潜在的协同作用.
研究的目的:
- 开发一个数学模型来量化ICD在优化联合RT和巨细胞免疫治疗中的作用.
- 在临床前模型中研究针对SIRPα-CD47检查点的有效性.
主要方法:
- 开发一个数学模型来评估ICD在组合治疗.
- 使用临床前小鼠数据,重点关注SIRPα-CD47检查点.
- 评估放射治疗 (RT) 单独与联合方法的对比.
主要成果:
- 单独使用RT就会诱导极小的ICD;破坏SIRPα-CD47轴显著增强了细胞和免疫激活.
- 该模型预测了最佳的RT剂量 (6-8 Gy) 以最大限度地提高ICD和剂量依赖的腹腔效应.
- 与其他治疗组合相比,SIRPα-Knockout巨细胞表现出优异的瘤杀伤活性.
结论:
- 为了设计有效的组合疗法,建立了一个定量框架.
- 利用ICD可以增强免疫检查点抑制和放射治疗协同作用,从而改善癌症治疗.
- 用巨细胞和优化的RT准SIRPα-CD47轴显示出显著的抗瘤潜力.
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
Cell-mediated Immune Responses
66.7K
Overview
66.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Vaccines
324
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
324
Immunodeficiency Diseases
890
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
890


